Co‐expression of the genes encoding transforming growth factor‐α and its receptor in papillary carcinomas of the thyroid

International Journal of Cancer

Volumn 46, Issue 3, 1990, Pages 382-387

  Aasland, R ^a   Akslen, L A ^a   Varhaug, J E ^a   Lillehaug, J R ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; RADIOISOTOPE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; GENES, STRUCTURAL, NEOPLASM; HUMAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA; SUPPORT, NON-U.S. GOV'T; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTORS; TUMOR CELLS, CULTURED;

EID: 0025078980     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910460308     Document Type: Article

References (52)

1. Expression of oncogenes in thyroid tumors: coex‐pression of c‐erb B2/neu and c‐erbB
2. The product of the human c‐erbB‐2 gene: a 185‐kilodalton glycoprotein with tyrosine kinase activity
3. The human platelet‐derived growth factor A chain: complementary DNA sequence, chromosomal localization and expression in human tumor cell lines
4. Coexpression of a PDGF‐like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation
5. Cloning of the human thyroglobulin complementary DNA
6. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
7. Single‐step method of RNA isolation by acid guanidinium‐thiocyanate‐phenol‐chloroform extraction
8. Production and auto‐induction of transforming growth factor‐α in human keratinocytes
9. Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v‐fos gene from mouse and human cells
10. Growth factors from murine sarcoma virus‐transformed cells
11. Transforming growth factor α
12. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors
13. Human transforming growth factor‐α: precursor structure and expression in E. coli
14. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β‐estradiol or v‐Ha‐ras oncogene
15. Overexpression of the human EGF receptor confers an EGF‐dependent transformed phenotype to NIH 3T3 cells
16. Autocrine interaction between TGF alpha and the EGF‐receptor: quantitative requirements for induction of the malignant phenotype
17. Overexpression of transforming growth factor α in psoriatic epidermis
18. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity
19. A new oncogene in human thyroid papillary carcinomas and their lymph‐nodal metastases
20. Subversion of growth regulatory pathways in malignant transformation
21. Sequence of cDNA encoding human insulin‐like growth factor I precursor
22. A Mr = 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the c‐erbB‐2 gene
23. Synergistic interaction of pl85c‐new and the EGF receptor leads to transformation of rodent fibroblasts
24. Developmental expression of rat transforming growth factor‐α mRNA
25. Activated ras oncogenes in human thyroid cancers
26. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
27. B‐cell stimula tory factor 1 and not interleukin‐2 is the autocrine growth factor for some helper T lymphocytes
28. Expression of trans forming growth‐factor alpha messenger RNA in the normal and neoplastic gastro‐intestinal tract
29. Epidermal growth factor‐like transforming growth factor. II. Interactions with epidermal growth factor receptors in human placenta and A431 cells
30. Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroidstimulating hormone on their growth
31. High levels of intracellular bombesin characterize human small‐cell lung carcinoma
32. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell line produce transforming factors
33. Spontaneous release of a factor with proper ties of T cell growth factor from a continuous line of primate tumor cells
34. Expression in rat fibroblasts of a human transforming growth factor‐α cDNA results in transformation
35. Transforming growth factor‐a: a more potent angiogeneric mediator than epidermal growth factor
36. Autocrine secretion and malignant trans formation of cells
37. Detection of activated ras oncogenes in human thyroid carcinomas
38. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors
39. Papillary thyroid carcino mas: morphology and prognosis
40. Isolation and characterization of rat and human glyceraldehyde‐3‐phosphate dehy drogenase cDNAs–genomic complexity and molecular evolution
41. Transforming growth factor a production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithe lial cells
42. Epidermal growth‐factor dependent transformation by a human EGF receptor proto‐oncogene
43. Dedifferentiation of cultured thyroid cells by epidermal growth factor: some insights into the mechanism
44. SGHTL‐34, a thyrotrophin‐responsive immortalized human thyroid cell line generated by transfection
45. Localization of cell synthesizing trans forming growth factor‐alpha mRNA in the mouse brain
46. Loss of dependence on IGF‐1 for proliferation of human thyroid adenoma cells
47. The TGF‐α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction
48. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in a A431 carcinoma cells
49. Elevation of transforming growth factor A and its relationship to the epidermal growth factor and a‐fetoprotein levels in patients with hepatocellular carcinoma